Literature DB >> 31148170

Leucine-rich repeat kinase 2 phosphorylation on synapsin I regulates glutamate release at pre-synaptic sites.

Antonella Marte1, Isabella Russo2, Claudia Rebosio3, Pierluigi Valente1,4, Elisa Belluzzi5, Francesca Pischedda6,7, Caterina Montani6,7, Chiara Lavarello8, Andrea Petretto8, Ernesto Fedele3,4, Pietro Baldelli1,4, Fabio Benfenati4,9, Giovanni Piccoli6,7, Elisa Greggio2, Franco Onofri1,4.   

Abstract

Leucine-rich repeat kinase 2 (LRRK2) is a large multidomain scaffolding protein with kinase and GTPase activities involved in synaptic vesicle (SV) dynamics. While its role in Parkinson's disease has been largely investigated, little is known about LRRK2 physiological role and until now few proteins have been described as substrates. We have previously demonstrated that LRRK2 through its WD40 domain interacts with synapsin I, an important SV-associated phosphoprotein involved in neuronal development and in the regulation of neurotransmitter release. To test whether synapsin I is substrate for LRRK2 and characterize the properties of its phosphorylation, we used in vitro kinase and binding assays as well as cellular model and site-direct mutagenesis. Using synaptosomes in superfusion, patch-clamp recordings in autaptic WT and synapsin I KO cortical neurons and SypHy assay on primary cortical culture from wild-type and BAC human LRRK2 G2019S mice we characterized the role of LRRK2 kinase activity on glutamate release and SV trafficking. Here we reported that synapsin I is phosphorylated by LRRK2 and demonstrated that the interaction between LRRK2 WD40 domain and synapsin I is crucial for this phosphorylation. Moreover, we showed that LRRK2 phosphorylation of synapsin I at threonine 337 and 339 significantly reduces synapsin I-SV/actin interactions. Using complementary experimental approaches, we demonstrated that LRRK2 controls glutamate release and SV dynamics in a kinase activity and synapsin I-dependent manner. Our findings show that synapsin I is a LRRK2 substrate and describe a novel mechanisms of regulation of glutamate release by LRRK2 kinase activity.
© 2019 International Society for Neurochemistry.

Entities:  

Keywords:  Parkinson’s disease; leucine-rich repeat kinase 2; neurotransmitter release; phosphorylation; synapsin I

Mesh:

Substances:

Year:  2019        PMID: 31148170     DOI: 10.1111/jnc.14778

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway.

Authors:  Guangna Yu; Xingyuan Sun; Li Li; Lijuan Huang; Hongbin Liu; Shuying Wang; Zhanjun Ren; Yanjiao Zhang
Journal:  Exp Ther Med       Date:  2019-12-31       Impact factor: 2.447

Review 2.  LRRK2 and Proteostasis in Parkinson's Disease.

Authors:  María Dolores Pérez-Carrión; Inmaculada Posadas; Javier Solera; Valentín Ceña
Journal:  Int J Mol Sci       Date:  2022-06-18       Impact factor: 6.208

3.  The LRRK2 N-terminal domain influences vesicle trafficking: impact of the E193K variant.

Authors:  Algerta Marku; Maria Dolores Perez Carrion; Francesca Pischedda; Antonella Marte; Zeila Casiraghi; Paola Marciani; Felix von Zweydorf; Christian Johannes Gloeckner; Franco Onofri; Carla Perego; Giovanni Piccoli
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379

4.  Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein.

Authors:  Charlotte F Brzozowski; Baraa A Hijaz; Vijay Singh; Nolwazi Z Gcwensa; Kaela Kelly; Edward S Boyden; Andrew B West; Deblina Sarkar; Laura A Volpicelli-Daley
Journal:  Acta Neuropathol Commun       Date:  2021-11-08       Impact factor: 7.801

5.  LRRK2-G2019S mice display alterations in glutamatergic synaptic transmission in midbrain dopamine neurons.

Authors:  Olga Skiteva; Ning Yao; Giacomo Sitzia; Karima Chergui
Journal:  J Neurochem       Date:  2022-02-27       Impact factor: 5.546

Review 6.  Molecular Pathways Involved in LRRK2-Linked Parkinson's Disease: A Systematic Review.

Authors:  Ailyn Irvita Ravinther; Hemaniswarri Dewi Dewadas; Shi Ruo Tong; Chai Nien Foo; Yu-En Lin; Cheng-Ting Chien; Yang Mooi Lim
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.